List view / Grid view




Sanofi sends half a million dengue vaccines to high risk Brazilians

15 August 2016 | By Sanofi

Results of the study affirm the vaccine's consistent efficacy in reducing dengue in two-thirds of the study participants, aged 9 and older. It also documents the ability of the vaccine to prevent 8 out of 10 hospitalisations and up to 93% of severe dengue cases in this age group during…